# Adaptive Radiation for Abdominopelvic Metastases

> **NCT05880667** · PHASE1 · RECRUITING · sponsor: **Fox Chase Cancer Center** · enrollment: 30 (estimated)

## Conditions studied

- Neoplasm - Soft Tissue Pelvis Malignant Secondary
- Malignant Neoplasm of Stomach

## Interventions

- **RADIATION:** Adaptive Stereotactic Body Radiation

## Key facts

- **NCT ID:** NCT05880667
- **Lead sponsor:** Fox Chase Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-08-01
- **Primary completion:** 2028-06-01
- **Final completion:** 2029-06-01
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2025-10-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05880667

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05880667, "Adaptive Radiation for Abdominopelvic Metastases". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT05880667. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*